Adam Woodrow, President & Chief Commercial at Paratek Pharmaceuticals, Inc. (PRTK), sold 4,563 shares at $3.47 ($16K) on 2022-10-28, disclosed to the SEC on 2022-11-01.
Scheduled sale ($16k) by President & Chief Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2021-12-15 | $269K | — | Filing → |
| PRTK | SELL | 2021-08-18 | $56K | — | Filing → |
| PRTK | SELL | 2021-06-08 | $333K | — | Filing → |